Rapid On-site Cytopathologic Evaluation in the Diagnosis of Hilar/Mediastinal Adenopathy
Rapid On-site Cytopathologic Evaluation in the Diagnosis of Hilar/Mediastinal Adenopathy
The purpose of this study is to determine whether rapid on-site cytopathologic evaluation
 (ROSE) can increase the diagnostic yield of transbronchial needle aspiration (TBNA) in the
 diagnosis of hilar and mediastinal lymphadenopathy.
Inclusion Criteria:

 -  18 years old and older

 -  Hilar and/or mediastinal lymphadenopathy (> 1 cm on the short axis, as assessed by
 contrast-enhanced CT scan (computed tomography))

 Exclusion Criteria:

 -  Uncontrolled coagulopathy

 -  Refusal to sign informed consent